Remission of recurrent gastrointestinal bleeding after septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy-associated acquired von willebrand syndrome

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 2, 2015, Pages 191-196

  Blackshear, J L ^a   Stark, M E ^a   Agnew, R C ^a   Moussa, I D ^b   Safford, R E ^a   Shapiro, B P ^a   Waldo, O A ^c   Chen, D ^d  

^a MAYO CLINIC   (United States)

^b First Coast Cardiovascular Institute   (United States)

^c MAYO CLINIC   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Cardiomyopathy hypertrophic; Endoscopy; Gastrointestinal; Hemorrhage; Von willebrand diseases; Von willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ABLATION THERAPY; ADULT; AGED; ANGIODYSPLASIA; ARTICLE; BLOOD TRANSFUSION; DOUBLE BALLOON ENTEROSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; MUSCLE RESECTION; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT DURATION; VON WILLEBRAND DISEASE; BLOOD; CARDIOMYOPATHY, HYPERTROPHIC; COMPLICATION; ECHOGRAPHY; HEART SURGERY; HEART VENTRICLE SEPTUM; MIDDLE AGED; REMISSION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY; VON WILLEBRAND DISEASES;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VON WILLEBRAND DISEASES;

EID: 84922912454     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12780     Document Type: Article

References (24)

1. Franchini M, Mannucci PM. von Willebrand disease-associated angiodysplasia: a few answers, still many questions. Br J Haematol 2013; 16: 177-82.
2. Eckman PM, John R. Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 2012; 125: 3038-47.
3. Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Trummer G, Berchtold-Herz M, Schlensak C, Zieger B. Acquired von Willebrand syndrome is an early-onset problem in ventricular assist device patients. Eur J Cardiothorac Surg 2011; 40: 1328-33.
4. Demirozu AT, Radovancevic R, Hochman LF. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2011; 30: 849-53.
5. Aggarwal A, Pant F, Kumar S, Sharma P, Gallagher C, Tatooles AJ, Pappas PS, Bhat G. Incidence and management of gastrointestinal bleeding with continous flow assist devices. Ann Thorac Surg 2012; 93: 1534-40.
6. Le Tourneau TL, Susen S, Caron C, Millaire S, Ennezat PV, Lamblin N, de Groote P, van Belle E, Marechaux BJ, Polge A-S, Vincentelli A, Mouquet F, Ennezat P-V, Lamblin N, de Groote P, van Belle E, Deklunder G, Goudemand J, Bauters C, Jude B. Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction. Circulation 2008; 118: 1550-7.
7. Kimmel DJ, Paster SB, Burstein J, Stovring J, Cochran PT. Cardiac disease and recurrent gastrointestinal bleeding: angiodysplasia with accompanying hypertrophic subaortic stenosis. Rocky Mt Med J 1977; 74: 316-19.
8. Bonneau A, Firouz-Abadi M, Cognault JP, Couradeau B, Dumas M. [Angiodysplasia of the ileum and cardiomyopathy]. Ann Cardiol Angeiol (Paris) 1984; 33: 389-94.
9. Alam M, Lewis JW Jr. Cessation of gastrointestinal bleeding from angiodysplasia after surgery for idiopathic hypertrophic subaortic stenosis. Am Heart J 1991; 121: 608-10.
10. Schwartz J, Rozenfeld V, Habot B. Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis - a case history. Angiology 1992; 43: 244-8.
11. Fujita H, Tomiyama J, Chuganji Y, Momoi M, Tanaka T. Diffuse angiodysplasia of the upper gastrointestinal tract in a patient with hypertrophic obstructive cardiomyopathy. Intern Med 2000; 39: 385-8.
12. Riis Hansen P, Hassager C. Septal alcohol ablation and Heyde's syndrome revisited. J Intern Med 2003; 253: 490-1.
13. Marti L, Anton R, Almela P, Benages A. Angiodislasia intestinal asociada a estenosis subaortica hipertrofica: una variante del sindrome de Heyde? Med Clin (Barc) 2006; 125: 635-6.
14. Shimizu M, Masai H, Miwa Y. Occult gastrointestinal bleeding due to acquired von Willebrand syndrome in a patient with hypertrophic obstructive cardiomyopathy. Intern Med 2007; 46: 481-5.
15. Blackshear JL, Schaff HV, Ommen SR, Chen D, Nichols WL Jr. Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willbrand syndrome: response to septal myectomy. Mayo Clinc Proc 2011; 86: 219-24.
16. Jackson CS, Gerson LB. Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis. Am J Gastroenterol 2014; 109: 474-83.
17. King RM, Pluth JR, Guiliani ER. The association of unexplained gastrointestinal bleeding with calcific aortic stenosis. Ann Thorac Surg 1987; 44: 514-16.
18. Thompson JL, Schaff HV, Dearani JA, Park SJ, Sundt TM, Suri R, Blackshear JL, Daly RC. Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome. J Thorac Cardiovasc Surg 2012; 144: 112-16.
19. Franchini M, Lippi I, Favaloro EJ. Etiology and diagnosis of acquired von Willebrand syndrome. Clin Adv Hematol Oncol 2010; 8: 20-4.
20. Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U. Diagnostic workup of patients with acquired von Willebrand syndrome: a single-center cohort study. J Thromb Haemost 2008; 6: 569-76.
21. Lenting P, Casari C, Christophe OD, Denis CV. von Willebrand factor: the old, the new, and the unknown. J Thromb Haemost 2012; 10: 2428-37.
22. Blackshear JL, Wysokinska EM, Safford RE, Thomas CS, Stark ME, Shapiro BP, Ung S, Johns GS, Chen D. Indexes of von Willebrand factor as biomarkers of aortic stenosis severity: (From the Biomarkers of Aortic Stenosis Severity BASS Study). Am J Cardiol 2013; 111: 374-81.
23. Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TAJ, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA, Randi AM. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011; 117: 1071-80.
24. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349: 343-9.